Skip to main content
Premium Trial:

Request an Annual Quote

FYR Diagnostics Wins $618K NIH Grant to Develop Acquired Epilepsy Assay

NEW YORK — FYR Diagnostics said today that it has been awarded a National Institutes of Health grant worth up to $618,086 to develop a microRNA-based assay for the detection of acquired epilepsy.

Acquired epilepsy is a form of the neurological disorder that results from other conditions such as stroke, infections, and traumatic brain injury. 

With the two-year Phase I Small Business Innovation Research grant, FYR will perform studies in animal models to determine whether plasma miRNAs can serve as biomarkers of acquired epilepsy caused by brain injury — known as post-traumatic epilepsy — using an assay based on a proprietary isothermal chemistry called ultrasensitive DNA amplification reaction, or UDAR. 

FYR President Sarj Patel said in a statement that the Missoula, Montana-based firm intends to ultimately commercialize the assay.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.